nbp stattic group (MedChemExpress)
99
Structured Review
MedChemExpress
nbp stattic group
Nbp Stattic Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 428 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nbp+stattic+group/Stattic/pm40591076-36-7-42
Average 99 stars, based on 428 article reviews
Nbp Stattic Group, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 428 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nbp+stattic+group/Stattic/pm40591076-36-7-42
Average 99 stars, based on 428 article reviews
nbp stattic group - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Saline:Article Title: Mechanistic study of butylphthalide in alleviating cerebral Edema after intracerebral Hemorrhage by regulating miR-7-5p expression. Article Snippet: Butylphthalide (NBP) has anti-inflammatory, antioxidant, anti-apoptotic, microcirculatory protection effects, and alleviates blood–brain barrier (BBB) damage and cerebral edema (Wang et al. 2023).. Currently, it is mainly used to treat ischemic stroke (Zeng et al. 2020), but has also shown to be effective in various other neurological diseases such as vascular dementia, Alzheimer’s disease, Parkinson’s disease, epilepsy, and autoimmune diseases (Niu et al. 2020, 2019; Huang et al. 2021), making it a promising therapeutic agent (Chen et al. 2019).. The pathological mechanisms of cerebral hemorrhage (ICH) involve mitochondrial dysfunction, inflammatory responses, oxidative stress, BBB damage, and cerebral edema (Crilly et al. 2021), all of which align with the mechanisms of NBP. Injection:Article Title: Mechanistic study of butylphthalide in alleviating cerebral Edema after intracerebral Hemorrhage by regulating miR-7-5p expression. Article Snippet: Butylphthalide (NBP) has anti-inflammatory, antioxidant, anti-apoptotic, microcirculatory protection effects, and alleviates blood–brain barrier (BBB) damage and cerebral edema (Wang et al. 2023).. Currently, it is mainly used to treat ischemic stroke (Zeng et al. 2020), but has also shown to be effective in various other neurological diseases such as vascular dementia, Alzheimer’s disease, Parkinson’s disease, epilepsy, and autoimmune diseases (Niu et al. 2020, 2019; Huang et al. 2021), making it a promising therapeutic agent (Chen et al. 2019).. The pathological mechanisms of cerebral hemorrhage (ICH) involve mitochondrial dysfunction, inflammatory responses, oxidative stress, BBB damage, and cerebral edema (Crilly et al. 2021), all of which align with the mechanisms of NBP. |